Suppr超能文献

影响肝硬化肝癌肝切除术后生存和复发的预后因素。

Prognostic factors affecting survival and recurrence after hepatic resection for hepatocellular carcinoma in cirrhotic liver.

机构信息

Gastroenterology Center, Mansoura University, Mansoura, Egypt.

出版信息

Langenbecks Arch Surg. 2010 Aug;395(6):625-32. doi: 10.1007/s00423-010-0643-0. Epub 2010 Apr 2.

Abstract

AIM

Hepatic resections for hepatocellular carcinoma (HCC) in cirrhotic liver are characterized by early recurrence and poor survival. In this study, we analyzed several factors affecting both survival and recurrence after hepatic resection.

PATIENTS AND METHODS

From October 1995 to April 2007, 550 patients underwent hepatic resections, of which, 175 patients had HCC in cirrhotic liver in Gastroenterology Surgical Center, Mansoura University, Egypt. There were 131 males (74.9%) and 44 females (25.1%) with a mean age of 54.8 +/- 9.2 years (ranges from 26 to 75 years).

RESULTS

Most of our patients were in Child's Pugh class A (86.9%). Major hepatic resection was done for 65 patients (37.1%), segmentectomy was done for 62 patients (35.4%), and localized resection was done for 48 patients (27.4%). Hospital mortality occurred in 16 (9.1%) patients, while hospital morbidity occurred in 40% of patients. The 1, 3, and 5 years survival were 68.6%, 29.6%, and 10.7%, respectively. The prognostic factors affecting recurrence were multifactorial, and the univariate analysis showed that multifocality of the tumor (p = 0.006), capsule (p = 0.001), staging (p = 0.001), blood transfusion (p = 0.02), infiltration of the cut margin (p = 0.001), vascular invasion (p = 0.006), and lymph nodes infiltration (p = 0.014) affect the recurrence rate, while with multivariate analysis, only cut margin was significantly affecting the recurrence (p = 0.026). Also, factors that significantly predicted survival were preoperative serum albumin (p = 0.005), tumor differentiation (p = 0.008), staging (p = 0.001), tumor's capsule (p = 0.001), cut margin (p = 0.031), vascular invasion (p = 0.049), and operative blood transfusion (p = 0.001). However, tumor differentiation (p = 0.048) was the only independent factor on multivariate analysis affecting long-term survival.

CONCLUSION

In our experience, the prognostic factors after resection for recurrence and survival are different and multifactorial. However, resection of HCC in cirrhotic liver with preserved liver function is the treatment of choice in the present time and can be done with favorable results.

摘要

目的

在肝硬化患者中进行肝细胞癌(HCC)肝切除术的特点是早期复发和生存不良。在这项研究中,我们分析了影响肝切除术后生存和复发的几个因素。

方法

1995 年 10 月至 2007 年 4 月,550 例患者接受了肝切除术,其中埃及曼苏拉大学胃肠外科中心的 175 例患者患有肝硬化肝癌。男性 131 例(74.9%),女性 44 例(25.1%),平均年龄 54.8±9.2 岁(26-75 岁)。

结果

我们的大多数患者为 Child-Pugh 分级 A(86.9%)。65 例患者行大肝切除术(37.1%),62 例患者行节段切除术(35.4%),48 例患者行局部切除术(27.4%)。16 例(9.1%)患者发生院内死亡,40%的患者发生院内并发症。1、3、5 年生存率分别为 68.6%、29.6%和 10.7%。影响复发的预后因素是多因素的,单因素分析显示肿瘤的多灶性(p=0.006)、包膜(p=0.001)、分期(p=0.001)、输血(p=0.02)、切缘浸润(p=0.001)、血管侵犯(p=0.006)和淋巴结浸润(p=0.014)影响复发率,而多因素分析仅显示切缘显著影响复发(p=0.026)。此外,术前血清白蛋白(p=0.005)、肿瘤分化(p=0.008)、分期(p=0.001)、肿瘤包膜(p=0.001)、切缘(p=0.031)、血管侵犯(p=0.049)和手术输血(p=0.001)等因素对生存率有显著影响。然而,肿瘤分化(p=0.048)是影响长期生存的唯一独立因素。

结论

根据我们的经验,复发和生存的术后预后因素是不同的,也是多因素的。然而,在保留肝功能的情况下切除肝硬化肝癌是目前的治疗选择,并且可以取得良好的效果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验